Blog

Clinical Research Units

Our phase I facilities consist of two state-of-the-art, fully equipped units for early phase studies, our hospital-based clinic at Uppsala University hospital and our clinic at Oscar II.

In contrast to many other CROs, CTC provides in-house clinical conduct at our First-in-Human (FIH) and Phase 0-II research units in Uppsala. Our clinical research units are truly the core of our company.

Oscar II:
This unit has 24 beds and is located, together with CTC’s head office, next to the hospital. At this research unit we offer Phase 0-IV studies, for example bioavailability and bioequivalence studies.

Akademiska:
Our 12-bed, First-in-Human unit, Akademiska, is perfectly located adjacent to the ICU, PET-centre and MRI-facilities at Uppsala University Hospital in Sweden.

Safety always comes first when planning, managing and running a First-in-Human study. CTC has experience in setting up adaptive FIH umbrella protocols including single and multiple ascending dose cohorts, food and drug-drug interaction parts, and patient cohorts. Regardless of the complexity of the study, safety is always a key focus. We conduct approximately five FIH studies a year.

Being a certified ERT-site for expert precision QT-assessments (EPQT), we may incorporate this service into your FIH study and provide the possibility for a TQT waiver.

As part of our FIH package we provide in-vitro risk assessment of immunological reactions, cytokine release and complement activation in a closed whole blood-loop system, in close collaboration with Immuneed AB.

Site Management Organisation (SMO) is a concept developed to facilitate the planning and conduct of Phase II-IV clinical trials where external or internal principal investigators may conduct studies at CTC using our systems and procedures. Our professional team of Research Nurses assist with logistics, administration, patient recruitment and clinical conduct. Our SMO site located in Uppsala (Oscar II) has all the equipment, infrastructure and experienced personnel needed to effectively support the study team.

Our educated and qualified staff consisting of Research Nurses, Physicians and Laboratory personnel constitute the heart of the clinic. We also have our own Recruitment team that constantly work with renewing our own healthy volunteer and patient database, supporting our Clinical Research Units as well as studies conducted at external clinics. As part of our recruitment, we also have a thorough pre-screening process to minimise screening failures.

Sandra GunnarssonDirector Clinical Research Units

Read more about Anna Waltari, Research Nurse

Clinical Operations

Clinical Operations at CTC provides key functions in all our studies regardless of whether we use our own clinics or external sites.

Our Clinical Operations team consists of Clinical Research Managers (CRMs), Medical Writers (MWs), Clinical Research Associates (CRAs) and Clinical Trial Assistants (CTAs) who coordinate each project from clinical study protocol development to clinical study report writing.

With a customer-focused and flexible approach, the CRMs coordinate multiple internal deliverables in full-service as well as part-service projects and are ready to solve any challenges that arise during a study.

Our professional teams apply their operational expertise to ensure proper planning, conduct and reporting of each trial, always with data quality and patient safety in mind and in compliance with ICH-GCP/ISO 14155, SOPs, guidelines, policies and best practices.  

Together the Clinical Operations team members have an average of 15+ years’ experience from the pharmaceutical industry, CROs, healthcare and academia in the development and use of pharmaceutical products, medical device and functional food.

Our Clinical Research Managers (CRMs) provide leadership and operational expertise through collaborative planning and execution, of Phase 0 to Phase II studies. They skilfully manage vendors and study teams to ensure effective start-up and regulatory compliant conduct of your clinical trial in close collaboration with each customer. Read more about our project management services.

Our Clinical Research Associates (CRAs/Study Monitors) continuously interact with the sites, supporting each Investigator to maximize quality, performance and CSP adherence. They identify, assess, monitor and mitigate risks that could affect the safety of the subjects or the quality of each clinical trial. Read more about our CRA and CTA services.

Our Clinical Trial Assistants (CTAs) thoroughly manage the Trial Master File to keep it inspection-ready and support the project teams in their day-to-day activities.

Our Medical Writers (MWs) proactively coordinate the cross-functional development of clinical study protocols and effectively and clearly analyse and communicate the clinical output from your study, orally and in writing. Read more about our medical writing services.

 Ann-Sofie SvenssonDirector Clinical Operations

Read more about Janet Håkansson, Clinical Research Manager

Pharmacovigilance

Pharmacovigilance is all about safer and more effective use of products throughout the product life cycle by collecting, detecting, assessing and managing adverse effects. Hence, preventing and minimizing the risk of any potential harm that may come to subjects or patients.

CTC’s Pharmacovigilance department encompasses experience with investigational medicinal products, advanced therapy medicinal products (ATMP) as well as medical devices in a wide range of indications and areas of use and the team carries out their work in accordance with good pharmacovigilance practice (GVP) and related regulations and directives.

Every medicinal product and medical device must have a satisfactorily completed clinical trial/investigation program establishing acceptable evidence of safety and efficacy before achieving marketing approval and or CE marking.

Our Pharmacovigilance team can offer full guidance in identifying your company’s specific needs regarding required pharmacovigilance activities, safety management and medical monitoring as well as tailor our services to provide suitable and reliable support to your team throughout the development process.

Read more about Medical MonitoringSafety ManagementMedical CodingSafety Committees and Medical Device services within our Pharmacovigliance department.

 Cornelia Lif-Tiberg, MD, Director Pharmacovigilance

Read more about Cornelia Lif-Tiberg

Biometrics

Our Biometrics team consists of eCRF Managers, Statistical Programmers, Pharmacokineticists and Biostatisticians and will guide you from study design to report. 

Prior to study start, our Biostatisticians assist with selection of endpoints and sample size calculations to ensure that your study meets the target. They write or review the statistical sections of the study protocol with the aim of optimising the study design. Read more about our biostatistical services. 

Our professional eCRF Managers will create a fit-for-purpose eCRF that reflects the study protocol and that allows for collection of reliable data for primary and secondary endpoints. As a flexible and cost-effective partner, we pride ourselves in delivering high-quality data in a timely manner. Read more about our eCRF and data management services. 

During the study, our eCRF Designers and Statistical Programmers work with high efficiency in assignments covering all aspects of Data Management – from eCRF design to database-lock and documentation. The Biometrics team also perform randomisations and interim analyses. Read more about our statistical programming services. 

After the study, our Statistical Programmers will display the data in tables, figures and listings as outlined in the statistical analysis plan (SAP) while our Biostatisticians and Pharmacokineticists take part in data analysis and writing of clinical study reports in accordance with agreed timelines.  Read more about our pharmacokinetic services. 

 Eva JacobssonDirector Biometrics

Read more about our pharmacokineticists